ClinConnect ClinConnect Logo
Search / Trial NCT04613583

Scottish Advanced Fetal Research Study

Launched by UNIVERSITY OF ABERDEEN · Nov 2, 2020

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Fetal Human Gestation Development Congenital Exposures Maternal Life Style Exogenous Chemicals Obesity Deprivation Alcohol Cigarette Endocrine Disruption

ClinConnect Summary

The Scottish Advanced Fetal Research Study is looking to understand how certain lifestyle factors and environmental exposures during pregnancy, such as smoking, drinking alcohol, or pollution, can affect the development of the fetus. Researchers want to learn about how these factors might lead to health problems later in life, like obesity or infertility. To do this, they will study fetuses between 7 and 20 weeks of gestation, gathering information and samples from both the mother and fetus to see how these exposures can impact development.

To participate in this study, women must be at least 16 years old, fluent in English, and at 7-20 weeks of pregnancy with a normal ultrasound. Unfortunately, women experiencing significant emotional distress or those with detected fetal anomalies cannot participate. If eligible, participants will help researchers gain valuable insights that could lead to better health outcomes for future generations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Women at 7-20 weeks of gestation (critical stage of fetal development).
  • Women aged 16 years and older, deemed capable of making a rational decision.
  • Absence of fetal anomaly at ultrasound scan (only normal fetuses are required).
  • Women who are fluent English speakers. This is in order to ensure the woman understands that fetal tissues will be collected.
  • Exclusion Criteria:
  • Women exhibiting considerable emotional distress.
  • Fetal anomalies identified at ultrasound scan.

About University Of Aberdeen

The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.

Locations

Aberdeen, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Paul A Fowler, PhD

Principal Investigator

University of Aberdeen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials